HealthTree
Foundation
FOR MULTIPLE MYELOMA
search
Sign In / Join
favorite
Donate
Education
Community
Cure Hub
Research
Get Involved
About Us
search
more_vert
close
person
Sign In / Create Account
Education
Community
Cure Hub
Research
Get Involved
About Us
Need help?
Chat with Us
♥
Donate
chevron_left
ASH 2022
1. Maintenance Cessation in MRD Negative Patients | Neha Korde, MD | ASH 2022
Video
bookmark_border
2. Individualized Prediction Model in Myeloma & Genome Sequencing | Francesco Maura, MD | ASH 2022
Video
bookmark_border
3. MODAKAFUSP ALFA (TAK-573) | Dan Vogl, MD, MSCE | ASH 2022
Video
bookmark_border
4. Opioid Use in Managing Pain in Myeloma | Karen Sweiss, PharmD | ASH 2022
Video
bookmark_border
5. Frailty and Multiple Myeloma | Hira Mian, MD, MSc | ASH 2022
Video
bookmark_border
6. MajesTEC-2 Trial | Emma Searle, MBChB MA MRCP FRCPath PhD | ASH 2022
Video
bookmark_border
7. Barriers to Participation in Hematology Trials | Shakira Grant, MBBS & Jiona Mills | ASH 2022
Video
bookmark_border
adjust
8. Talquetamab | Ajai Chari, MD | ASH 2022
Video
bookmark_border
9. OPTIMUM MUK Nine Trial | Martin Kaiser, MD | ASH 2022
Video
bookmark_border
10. How to Better Diagnose Patients With High-Risk Myeloma | Martin Kaiser, MD | ASH 2022
Video
bookmark_border
11. Waitlists for CAR-T | Samer Al'Hadidi, MD | ASH 2022
Video
bookmark_border
12. The Need For New Clinical Trial Strategies | Hearn J. Cho, MD | ASH 2022
Video
bookmark_border
13. Advancements in Immunotherapy Agents | Hearn J. Cho, MD | ASH 2022
Video
bookmark_border
14. Nutrivention Trials | Urvi Shah, MD | ASH 2022
Video
bookmark_border
15. Building a Dietary Evidence Symposium | Urvi Shah, MD | ASH 2022
Video
bookmark_border
16. T Cell Redirection Therapy | Tarek Mouhieddine, MD | ASH 2022
Video
bookmark_border
17. Bispecifics | Urvi Shah, MD | ASH 2022
Video
bookmark_border
18. CAR-T Therapy | Santiago Thibaud, MD | ASH 2022
Video
bookmark_border
19. CAR-T BMS-986354 | Luciano Costa, MD, PhD | ASH 2022
Video
bookmark_border
20. Maintenance Cessation in MRD Negative Patients | Neha Korde, MD | ASH 2022
Video
bookmark_border
21. Effect of a Covid Infection in Patients Prior to Transplant | Meera Mohan, MD, MS, FACP | ASH 2022
Video
bookmark_border
22. New Developments at ASH | Rafat Abonour, MD | ASH 2022
Video
bookmark_border
23. Quad Therapies and Side Effects | Nathan Sweeney, PhD | ASH 2022
Video
bookmark_border
24. Patient Top Concerns at and Since Diagnosis | Nathan Sweeney, PhD | ASH 2022
Video
bookmark_border
25. Bispecific T Cell Engagers | Noopur Raje, MD | ASH 2022
Video
bookmark_border
26. Revlimid Refractory Patients in Daratumumab Clinical Trials | Binod Dhakal, MD | ASH 2022
Video
bookmark_border
27. MRD Detection in Blood | Bruno Paiva, PhD | ASH 2022
Video
bookmark_border
28. iStopMM Trial - Covid Vaccine and Impact on Myeloma | Malin Hultcrantz, MD, PhD | ASH 2022
Video
bookmark_border
29. Post BCMA Therapy | Gurbakhash Kaur, MD | ASH 2022
Video
bookmark_border
30. LINKER-MM1 Study in RRMM | Naresh Bumma, MD | ASH 2022
Video
bookmark_border
31. Updates on Teclistamab, Talquetamab, and CARVYKTI | DOCTOR, MD PHD | ASH 2022
Video
bookmark_border
32. Bispecific Antibodies | Joshua Richter, MD | ASH 2022
Video
bookmark_border
33. Prospective evaluation of the biology of aggressive myeloma lesions after induction | ASH 2022
Video
bookmark_border
34. Detecting myeloma with single cell sequencing | Scott Goldsmith, MD | ASH 2022
Video
bookmark_border
35. What to Look Forward to at ASH | Ola Landgren, MD, PhD | ASH 2022
Video
bookmark_border
Bookmark
bookmark_border
Quizzes
visibility_off
Share
share
Talquetamab | Ajai Chari, MD | ASH 2022
Last year